Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (311-320 of 334) with videos related to

Pageof 34
Sort By:
British Journal of Haematology|August 4, 2023
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with responsePetya Apostolova, Stefanie Kreutmair, Cristina Toffalori, et al.
The Journal of Clinical Investigation|April 28, 2020
Loss of the Fanconi anemia-associated protein NIPA causes bone marrow failureStefanie Kreutmair, Miriam Erlacher, Geoffroy Andrieux, et al.
Bone Marrow Transplantation|June 3, 2025
Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMTKatia Perruccio, Katherine N Ward, Gloria Tridello, et al.
Blood|July 5, 2024
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHDYu Akahoshi, Nikolaos Spyrou, Daniela Weber, et al.
The Journal of Experimental Medicine|July 8, 2025
Gut microbiota-derived TMAVA is a modulator of acute CNS-GVHDSangya Chatterjee, Tamina Rückert, Ina Martin, et al.
Blood Advances|February 7, 2024
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysisYu Akahoshi, Nikolaos Spyrou, Matthias Hoepting, et al.
Nature Medicine|March 27, 2019
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantationCristina Toffalori, Laura Zito, Valentina Gambacorta, et al.
Blood Advances|August 15, 2025
The MAGIC Composite Response: A Novel Endpoint Integrating Clinical and Biomarker Parameters for Acute GVHDYu Akahoshi, Joseph Portelli, Nikolaos Katsivelos, et al.
Nature Immunology|February 2, 2023
Phosphoinositide acyl chain saturation drives CD8<sup>+</sup> effector T cell signaling and functionJoy Edwards-Hicks, Petya Apostolova, Joerg M Buescher, et al.
Nature Cell Biology|July 15, 2025
Differentiation, ageing and leukaemia alter the metabolic profile of human bone marrow haematopoietic stem and progenitor cellsMaria-Eleni Lalioti, Mari Carmen Romero-Mulero, Noémie Karabacz, et al.
Pageof 34

Showing results (311-320 of 334) with videos related to

Sort By:
Pageof 34
British Journal of Haematology|August 4, 2023
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with responsePetya Apostolova, Stefanie Kreutmair, Cristina Toffalori, et al.
The Journal of Clinical Investigation|April 28, 2020
Loss of the Fanconi anemia-associated protein NIPA causes bone marrow failureStefanie Kreutmair, Miriam Erlacher, Geoffroy Andrieux, et al.
Bone Marrow Transplantation|June 3, 2025
Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMTKatia Perruccio, Katherine N Ward, Gloria Tridello, et al.
Blood|July 5, 2024
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHDYu Akahoshi, Nikolaos Spyrou, Daniela Weber, et al.
The Journal of Experimental Medicine|July 8, 2025
Gut microbiota-derived TMAVA is a modulator of acute CNS-GVHDSangya Chatterjee, Tamina Rückert, Ina Martin, et al.
Blood Advances|February 7, 2024
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysisYu Akahoshi, Nikolaos Spyrou, Matthias Hoepting, et al.
Nature Medicine|March 27, 2019
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantationCristina Toffalori, Laura Zito, Valentina Gambacorta, et al.
Blood Advances|August 15, 2025
The MAGIC Composite Response: A Novel Endpoint Integrating Clinical and Biomarker Parameters for Acute GVHDYu Akahoshi, Joseph Portelli, Nikolaos Katsivelos, et al.
Nature Immunology|February 2, 2023
Phosphoinositide acyl chain saturation drives CD8<sup>+</sup> effector T cell signaling and functionJoy Edwards-Hicks, Petya Apostolova, Joerg M Buescher, et al.
Nature Cell Biology|July 15, 2025
Differentiation, ageing and leukaemia alter the metabolic profile of human bone marrow haematopoietic stem and progenitor cellsMaria-Eleni Lalioti, Mari Carmen Romero-Mulero, Noémie Karabacz, et al.
Pageof 34